Scientists comment on a study examining incidence of type 1 diabetes in children receiving rotavirus vaccine; secondary analysis suggests vaccine not cause of observed 11% relative increase, as ...

‘Petrelintide, a human amylin analogue for the treatment of obesity (ZUPREME 1): a randomised, double-blind, placebo-controlled, phase 2 trial’ by W Timothy Garvey et al. was published in The Lancet ...

‘Prenatal exposure to maternal depression and antidepressants and neurodevelopmental outcomes: A population cohort study’ by Saraid McIlvride et al. was published in PLOS Medicine at 19:00 UK time on ...

September 28, 2026 expert reaction to umbrella review of studies looking at screen use and child and adolescent development . Scientists comment on an umbrella review of studies l ...

‘GLP-1 receptor agonist exposure in the periconceptional period and adverse obstetric outcomes: A systematic review and meta-analysis’ by Francesco D’Antonio et al. was published in Med at 16:00 UK ...

Scientist comment on a systemic review and meta-analysis, published in The Lancet Obstetrics, Gynaecology & Women’s Health, looking at preconception, pregnancy, and postnatal use of GLP-1 RAs in women ...

Scientists react to pre-print on the genetics of the bacteria responsible for the Kent meningitis outbreak which is due to be presented at the UKHSA Conference 2026. Prof Robert Heyderman, Professor ...

‘Ultra-processed food consumption and risk of multiple chronic diseases among 8,819,894 adults from 51 prospective cohorts: a dose-response meta-analysis’ by Xiao Liu et al. was published in Family ...

September 23, 2026 expert reaction to oral menopause hormone therapy linked to increased risk of blood clots, and cardiovascular disease at higher doses . Scientists comment on a ...

Scientist comment on a study, published in Diabetes, on UPF consumption, physical activity, genetic susceptibility and type 2 diabetes, which is being presented at the European Association for the ...

‘Oral vitamin C supplementation in patients with clonal cytopenia of undetermined significance or lower-risk myeloid malignancies: Results from EVITA, a phase 2 randomized, placebo-controlled trial’ ...

Scientists comment on a study, published in Environmental Health Perspectives, looking at chemical production volumes, sources, intake levels, emissions of breast-cancer relevant chemicals.